A Study to Learn About a Vaccine Against E Coli in Healthy Adults
Pfizer · NCT07122986
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–64 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 1
- Target enrollment
- 310
- US sites recruiting
- 11
- Study start
- August 11, 2025
- Record last updated
- April 30, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study evaluates an investigational vaccine designed to protect against Escherichia coli (E coli). The primary objective is to assess the safety and tolerability of E coli vaccines administered intramuscularly to healthy adults.
Being studied: E coli vaccine 1 Dose A; E coli vaccine 1 Dose B; E coli vaccine 2; E coli vaccine 3; E coli Vaccine 4 Dose A; E coli Vaccine 4 Dose B; E coli Vaccine 4 Dose C; E coli Vaccine 5 Dose A; E coli Vaccine 5 Dose B; Placebo
Conditions: Healthy Participants
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Ages Eligible for Study: 18 to 64 Years (Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: Yes
Key Inclusion Criteria
- Adult Participants >= 18 through \< 64 years of age at the time of enrollment.
- Healthy participants as determined by medical history, physical examination, and clinical judgement of the investigator to be eligible for inclusion in the study.
Key Exclusion Criteria
- Severe adverse reaction history associated with a vaccine and/or severe allergic reaction (eg, anaphylaxis) to any component of the study intervention(s).
- Immunocompromised individuals with known or suspected immunodeficiency, as determined by history and/or laboratory/physical examination.
- Women who are pregnant, plan to become pregnant during the study, or are breastfeeding.
Recruiting US locations
Anaheim Clinical Trials, LLC
Anaheim, CA 92801
Orange County Research Center
Lake Forest, CA 92630
Diablo Clinical Research, Inc.
Walnut Creek, CA 94598
Miami Eye Institute
Hollywood, FL 33024
Research Centers of America
Hollywood, FL 33024
NYU Langone Health
New York, NY 10016
CTI Clinical Research Center
Cincinnati, OH 45212
Senders Pediatrics
South Euclid, OH 44121
Alliance for Multispecialty Research, LLC
Knoxville, TN 37909
Alliance for Multispecialty Research, LLC
Knoxville, TN 37920
University Eye Specialists, P.C. (Ophthalmologist)
Maryville, TN 37803
Study contacts (from the official record)
- Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Similar studies in California
All vaccine studies in California →- RecruitingHealthy volunteersPhase 1/Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Blue Lake Biotechnology Inc.
- Location
- La Mesa, CA + 13 other US sites
- Eligibility basics
- Ages 6 mo–5
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Huntington Beach, CA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Madera, CA + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.
Sanofi
- Location
- Rolling Hills Estates, CA + 15 other US sites
- Eligibility basics
- Ages 18+